Literature DB >> 19074615

Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy.

Chad Dickey1, Clara Kraft, Umesh Jinwal, John Koren, Amelia Johnson, Laura Anderson, Lori Lebson, Daniel Lee, Dennis Dickson, Rohan de Silva, Lester I Binder, David Morgan, Jada Lewis.   

Abstract

We have extensively analyzed the biochemical and histochemical profiles of the tau protein from the rTg4510 transgenic mouse model in which the animals uniquely develop forebrain tau pathologies similar to those found in human tauopathies. Levels of several soluble phosphorylated tau species were highest at 1 month relative to later time points, suggesting that certain tau hyperphosphorylation events were insufficient to drive tangle formation in young mice. Despite a robust, pre-tangle-like accumulation of phospho-tau in 1-month-old mice, this material was cleared by 3 months, indicating that the young mouse brain either fails to facilitate tau insolubility or possesses an enhanced ability to clear tau relative to the adult. We also found that while heat shock protein expression increased with normal aging, this process was accelerated in rTg4510 mice. Moreover, by exploiting an exon 10 (-) specific antibody, we demonstrated that endogenous mouse tau turnover was slowed in response to human tau over-expression, and that this endogenous tau adopted disease-related properties. These data suggest that a younger brain fails to develop lasting tau pathology despite elevated levels of phosphorylated tau, perhaps because of reduced expression of stress-related proteins. Moreover, we show that the active production of small amounts of abnormal tau protein facilitates dysfunction and accumulation of otherwise normal tau, a significant implication for the pathogenesis of patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074615      PMCID: PMC2631335          DOI: 10.2353/ajpath.2009.080764

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  The Drosophila homolog of C. elegans PAR-1 organizes the oocyte cytoskeleton and directs oskar mRNA localization to the posterior pole.

Authors:  J M Shulman; R Benton; D St Johnston
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Mixed results for disease-modification strategies for Alzheimer's disease.

Authors:  Alisa Opar
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

3.  Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.

Authors:  Kentaro Tanemura; Miyuki Murayama; Takumi Akagi; Tsutomu Hashikawa; Takashi Tominaga; Michinori Ichikawa; Haruyasu Yamaguchi; Akihiko Takashima
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

4.  Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.

Authors:  Marcia N Gordon; Leigh A Holcomb; Paul T Jantzen; Giovanni DiCarlo; Donna Wilcock; Kristal W Boyett; Karen Connor; Jason Melachrino; James P O'Callaghan; Dave Morgan
Journal:  Exp Neurol       Date:  2002-02       Impact factor: 5.330

5.  Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity.

Authors:  Jacek Biernat; Yong-Zhong Wu; Thomas Timm; Qingyi Zheng-Fischhöfer; Eckhard Mandelkow; Laurent Meijer; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

6.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

7.  Tau filament formation in transgenic mice expressing P301L tau.

Authors:  J Götz; F Chen; R Barmettler; R M Nitsch
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats.

Authors:  L Sun; S Y Liu; X W Zhou; X C Wang; R Liu; Q Wang; J Z Wang
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila.

Authors:  Isao Nishimura; Yufeng Yang; Bingwei Lu
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

10.  Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.

Authors:  R de Silva; T Lashley; G Gibb; D Hanger; A Hope; A Reid; R Bandopadhyay; M Utton; C Strand; T Jowett; N Khan; B Anderton; N Wood; J Holton; T Revesz; A Lees
Journal:  Neuropathol Appl Neurobiol       Date:  2003-06       Impact factor: 8.090

View more
  48 in total

Review 1.  Tau-targeted treatment strategies in Alzheimer's disease.

Authors:  Jürgen Götz; Arne Ittner; Lars M Ittner
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.

Authors:  Laura J Blair; Bryce A Nordhues; Shannon E Hill; K Matthew Scaglione; John C O'Leary; Sarah N Fontaine; Leonid Breydo; Bo Zhang; Pengfei Li; Li Wang; Carl Cotman; Henry L Paulson; Martin Muschol; Vladimir N Uversky; Torsten Klengel; Elisabeth B Binder; Rakez Kayed; Todd E Golde; Nicole Berchtold; Chad A Dickey
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  Heat shock protein responses to aging and proteotoxicity in the olfactory bulb.

Authors:  Tyler S Crum; Amanda M Gleixner; Jessica M Posimo; Daniel M Mason; Matthew T Broeren; Scott D Heinemann; Peter Wipf; Jeffrey L Brodsky; Rehana K Leak
Journal:  J Neurochem       Date:  2015-03-05       Impact factor: 5.372

Review 4.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

Review 5.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

6.  Hsp90 activator Aha1 drives production of pathological tau aggregates.

Authors:  Lindsey B Shelton; Jeremy D Baker; Dali Zheng; Leia E Sullivan; Parth K Solanki; Jack M Webster; Zheying Sun; Jonathan J Sabbagh; Bryce A Nordhues; John Koren; Suman Ghosh; Brian S J Blagg; Laura J Blair; Chad A Dickey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

7.  Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation.

Authors:  Jose F Abisambra; Umesh K Jinwal; Laura J Blair; John C O'Leary; Qingyou Li; Sarah Brady; Li Wang; Chantal E Guidi; Bo Zhang; Bryce A Nordhues; Matthew Cockman; Amirthaa Suntharalingham; Pengfei Li; Ying Jin; Christopher A Atkins; Chad A Dickey
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

8.  Noncontact Rotational Head Injury Produces Transient Cognitive Deficits but Lasting Neuropathological Changes.

Authors:  Jonathan J Sabbagh; Sarah N Fontaine; Lindsey B Shelton; Laura J Blair; Jerry B Hunt; Bo Zhang; Joseph M Gutmann; Daniel C Lee; John D Lloyd; Chad A Dickey
Journal:  J Neurotrauma       Date:  2016-03-16       Impact factor: 5.269

9.  Animal models for Alzheimer's disease and frontotemporal dementia: a perspective.

Authors:  Jürgen Götz; Naeman N Götz
Journal:  ASN Neuro       Date:  2009-11-09       Impact factor: 4.146

10.  Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Yazi D Ke; Fabien Delerue; Amadeus Gladbach; Jürgen Götz; Lars M Ittner
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.